Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gwenn Hansen currently holds 62,310 shares of Nurix Therapeutics, Inc. (NRIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gwenn Hansen has been a net seller of NRIX stock. They have purchased $0 and sold $890.6K worth of shares.
Gwenn Hansen's most recent insider trade was on Aug 5, 2026, when they sold 4,356 shares at $0.00 per share.
Gwenn Hansen serves as Executive at Nurix Therapeutics, Inc. (NRIX). They have executed 87 insider transactions totaling $890.6K over their tenure at the company.
Gwenn Hansen holds the position of Executive at Nurix Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Gwenn Hansen has shown a selling trading pattern, with $0 in total purchases and $890.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gwenn Hansen was on Aug 5, 2026, when they sold $108.9K worth of NRIX shares. This transaction involved 4,356 shares at $25.00 per share.
Gwenn Hansen currently owns 62,310 shares of Nurix Therapeutics, Inc. (NRIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gwenn Hansen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gwenn Hansen has 87 Form 4 filings on record as an insider at Nurix Therapeutics, Inc..
Set alerts for Gwenn Hansen and 40,000+ other insiders.